-
Need a Ride?Cancer center expands pilot program to provide transportation for patients to get to appointments.
by Karen Blum
-
February 4: The Week in Cancer NewsCAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
by Eric Fitzsimmons
-
January 28: The Week in Cancer NewsPharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.
by Marci A. Landsmann
-
January 21: The Week in Cancer NewsMetastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
by Kevin McLaughlin
-
January 14: The Week in Cancer NewsCancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.
by Eric Fitzsimmons
-
Cancer, On and Off StageErin Cronican, who has stage IV breast cancer, plays the lead role of a professor diagnosed with metastatic ovarian cancer in the New York City production of Wit.
by Pamela Rafalow Grossman
-
January 7: The Week in Cancer NewsThree out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
by Marci A. Landsmann
-
Acknowledging the Stress of CancerA patient advocate session at the San Antonio Breast Cancer Symposium offered practical tips for dealing with cancer.
by Marci A. Landsmann
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
